Abn Amro Investment Solutions Astrazeneca PLC Transaction History

Abn Amro Investment Solutions

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Sep 04, 2025	SELL	$63.2 - $79.58 $877,342 - $1.1 Million	-13,882 Closed	0 $0
Q3 2024 Sep 04, 2025	BUY	$76.67 - $87.62 $1.06 Million - $1.22 Million	13,882 New	13,882 $1.08 Billion
Q3 2023 Sep 05, 2025	SELL	$64.85 - $71.7 $403,237 - $445,830	-6,218 Closed	0 $0
Q2 2023 Sep 05, 2025	BUY	$69.91 - $75.81 $23,419 - $25,396	335 Added 5.69%	6,218 $445 Million
Q1 2023 Sep 05, 2025	BUY	$63.15 - $71.6 $371,511 - $421,222	5,883 New	5,883 $408 Million

1,501

500M

5.64M

3.2M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.